Novartis, Actavis Settle Patent Infringement Suit

By Kelly Knaub (January 14, 2016, 7:45 PM EST) -- Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in New Jersey federal court on Thursday....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!